Log in to save to my catalogue

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8968fbb86864e12864baafe3b85e366

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease

About this item

Full title

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-12, Vol.14 (1), p.31822-12, Article 31822

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Lipocalin-2 (LCN2) is an acute-phase secretory molecule significantly upregulated in various neuroinflammatory and demyelinating conditions. Krabbe disease (KD) is a neurodegenerative lysosomal disorder caused by a galactosylceramidase (GALC) deficiency, accumulating cytotoxic psychosine in nervous systems, and subsequent neuroinflammation. Here, w...

Alternative Titles

Full title

Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e8968fbb86864e12864baafe3b85e366

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e8968fbb86864e12864baafe3b85e366

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-82927-1

How to access this item